Evidence map›Paper›PMID 35237277›Full record

ArticleFrontiers in immunology2022

Activation of RARα Receptor Attenuates Neuroinflammation After SAH

Yang Tian, Binbing Liu, Yuchen Li, Yongzhi Zhang, Jiang Shao, Pei Wu, Chao Xu, Guangduo Chen, Huaizhang Shi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it, 143 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Psoriasis intervention by Huai'er (): unveiling novel targetsnetwork pharmacology.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yang TianDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Binbing LiuDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yuchen LiDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Yongzhi ZhangDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Jiang ShaoDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Pei WuDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Chao XuDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China.
Guangduo ChenDepartment of Cardiology, Fujian Medical University Union Hospital, Fuzhou, China.
Huaizhang ShiDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China.
First Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CNFujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeSubarachnoid hemorrhage (SAH) is a life-threatening subtype of stroke with high rates of mortality. In the early stages of SAH, neuroinflammation is one of the important mechanisms leading to brain injury after SAH. In various central nervous system diseases, activation of RARα receptor has been proven to demonstrate neuroprotective effects. This study aimed to investigate the anti-inflammatory effects of RARα receptor activation after SAH.

methodsInternal carotid artery puncture method used to established SAH model in Sprague-Dawley rats. The RARα specific agonist Am80 was injected intraperitoneally 1 hour after SAH. AGN196996 (specific RARα inhibitor), Msr1 siRNA and LY294002 (PI3K-Akt inhibitor) were administered

conclusionActivation of the RARα receptor attenuated neuroinflammation by promoting M1-to-M2 phenotypic polarization in microglia and regulating the Mafb/Msr1/PI3K-Akt/NF-κB pathway. RARα might serve as a potential target for SAH therapy.

Indexed as

NF-kappa BSubarachnoid HemorrhageAnimalsMafB Transcription FactorMicrogliaNeuroinflammatory DiseasesOncogene ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleyRNA, Small InterferingSignal TransductionMafb protein, ratMafB Transcription FactorNF-kappa BOncogene ProteinsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, Small InterferingMsr1neuroinflammationretinoic acid receptor αsubarachnoid hemorrhagetamibarotene

Identifiers

PMID35237277
PMCPMC8882645
OpenAlexW4212776578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.